Need Help?

Measurement of altered CTCF binding in cancer using ChIP-seq

Sequencing data for the paper: Direct analysis of transcription factor protected cfDNA in plasma by ChIP-seq: Measurement of altered CTCF binding in cancer is a novel biomarker for liquid biopsy. This dataset contains 160 CRAM files containing Illumina NovaSeq reads aligned using BWA to the UCSC hg38 reference. These 160 samples belong to four experiments - a 70 sample development cohort, a 24 sample validation cohort, a second 58 sample validation cohort and eight samples from an enrichment recovery experiment, consisting of a CTCF and a Total sample from each of four cancer patients.

Request Access

DUO:0000006
version: 2021-02-23

health or medical or biomedical research

This data use permission indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry.

DUO:0000015
version: 2021-02-23

no general methods research

This data use modifier indicates that use does not allow methods development research (e.g., development of software or algorithms).

DUO:0000018
version: 2021-02-23

not for profit, non commercial use only

This data use modifier indicates that use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.

DUO:0000019
version: 2021-02-23

publication required

This data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community.

DUO:0000020
version: 2021-02-23

collaboration required

This data use modifier indicates that the requestor must agree to collaboration with the primary study investigator(s).

DUO:0000024
version: 2021-02-23

publication moratorium

This data use modifier indicates that requestor agrees not to publish results of studies until a specific date.

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

DUO:0000028
version: 2021-02-23

institution specific restriction

This data use modifier indicates that use is limited to use within an approved institution.

VOLITION DATA ACCESS POLICY

About This Policy Belgian Volition SRL ("Volition") has deposited one or more controlled-access datasets of genetic and phenotypic data with the European Genome-phenome Archive ("EGA"), a secure archive jointly operated by the European Molecular Biology Laboratory ("EMBL") and the Centre for Genomic Regulation ("CRG"). This Data Access Policy ("Policy") sets out who may apply for access to those datasets, on what terms, and how applications are reviewed. EGA does not grant or deny access. All access decisions are made exclusively by Volition's Data Access Committee ("DAC"). EGA implements DAC decisions and provides the infrastructure through which approved users download data. This Policy is a public-facing summary. Approved users are bound by the full terms of the Volition Data Access Agreement ("DAA"), which must be signed before access is granted. ________________________________________ Data Use Conditions (DUO Codes) The following GA4GH Data Use Ontology codes apply to these datasets. Prospective applicants should review these codes carefully before applying, as they define the conditions under which access may be granted. DUO Code Shorthand Meaning What this means for applicants DUO:0000006 HMB Health/Medical/Biomedical Research Use is allowed for health, medical, and biomedical research purposes. This does not include the study of population origins or ancestry. DUO:0000015 NMDS No General Methods Research Use does not permit methods development research (e.g., development of software or algorithms) as a primary purpose. DUO:0000018 NPUNCU Not for Profit, Non-Commercial Use Only Use is limited to not-for-profit organisations. Use is limited to non-commercial purposes. The data may not be used to generate revenue, develop commercial products or services, or support for-profit activities, regardless of the applicant's organisational status. DUO:0000019 PUB Publication Required Approved users agree to make results available to the wider scientific community. DUO:0000024 MOR Publication Moratorium Users agree not to submit global analyses for publication until the moratorium period has elapsed. DUO:0000027 PS Project Specific Restriction Use is limited to the approved research project described in the application. DUO:0000028 IS Institution Specific Restriction Use is limited to the approved institution named in the application. DUO:0000026 US User Specific Restriction Use is limited to the named authorised personnel listed in the application. DUO:0000020 COL Collaboration Required Approved users must agree to collaborate with Volition on the relevant study, including with respect to data interpretation and publication. Eligibility To be eligible for access, the purpose of the application must comply with the above Data Use Conditions and meet all of the following criteria: 1. Research purpose. The proposed use must constitute a legitimate health, medical, or biomedical research purpose. Research into population origins or ancestry is not permitted. Data may not be used for commercial purposes without Volition's prior written consent. 2. Institutional affiliation. The applicant must be affiliated with a recognised research or academic institution and must hold a verifiable institutional email address. Applications from individuals without institutional affiliation will not be considered. 3. Non-profit organisation. The applicant's institution must be a not-for-profit organisation.. Commercial entities and for-profit organisations are not eligible to apply without Volition's prior written consent. 4. Non-commercial use. The proposed use of the data must be non-commercial in nature. The data may not be used to generate revenue, develop products or services for sale, or otherwise support for-profit activities. This restriction applies to the nature of the use itself, regardless of whether the applicant's institution is a not-for-profit organisation. 5. Bona fide researcher. The applicant (Principal Investigator) must be an appropriately qualified researcher. The DAC will verify credentials via publicly available sources such as PubMed, ResearchGate, or institutional websites. 6. Collaboration agreement. Applicants must confirm in writing their agreement to collaborate with Volition as part of their application. 7. Ethics approval. Where the proposed research requires ethics board or institutional review board ("IRB") approval in the applicant's jurisdiction, evidence of such approval must be provided. 8. Data security. The applicant's institution must have appropriate technical and organisational measures in place to protect the data in accordance with the minimum security standards set out in the DAA. How to Apply 1. Create an EGA account. If you do not already have one, register at ega-archive.org. 2. Submit a data access request. Navigate to the dataset page on EGA and submit a request. You will be asked to provide: 2.1. a project title and scientific abstract (maximum 500 words) describing the research question, aims, methods, and intended duration; 2.2. details of the applicant and the not-for-profit organization to which the applicant is affiliated; 2.3. a list of all authorised personnel who will access the data, including names, job titles, institutional email addresses, and the supervising Principal Investigator; 2.4. a list of individuals who require EGA accounts for data download; 2.5. evidence of relevant research credentials (up to three recent publications, or a description of relevant expertise); and 2.6. evidence of ethics or IRB approval, where required; and 2.7. the signed Data Access Agreement. 3. Sign the DAA. Download the Data Access Agreement from the dataset page. Complete and sign it, then upload the signed copy as part of your application. 4. Collaboration confirmation. Include written confirmation in your application that you agree to collaborate with Volition's Principal Investigator(s) on the study. Application Review Applications are reviewed by Volition's DAC in accordance with its Terms of Reference. The DAC aims to respond to all applications within 14 calendar days of receipt. Decisions are based solely on scientific and ethical criteria aligned with the informed consent under which the data was collected. The DAC will not deny access on grounds of scientific competitiveness. Where further information is required, the DAC will contact the applicant directly. ________________________________________ Criteria for Approval The DAC will approve an application if: 1. the proposed use is consistent with the original informed consent; 2. the proposed use is consistent with the above Data Use Conditions 3. the applicant is a bona fide researcher with appropriate qualifications and institutional affiliation; 4. the applicant's institution has adequate data security arrangements; 5. the signed DAA has been received; 6. the applicant has confirmed their agreement to collaborate with Volition; 7. there is no record of prior non-compliance with a data access agreement by the applicant or their institution; and 8. the application is otherwise consistent with this policy. ________________________________________ Grounds for Rejection The DAC may refuse an application where: 1. the proposed use falls outside the scope of the original informed consent under which the data was collected; 2. the proposed use is inconsistent with the above Data Use Conditions 3. the applicant lacks verifiable institutional affiliation; 4. the scientific justification is insufficient or implausible; 5. the proposed data security arrangements are inadequate; 6. there is a prior record of breach of a data access agreement; 7. the proposed use carries a material risk of re-identifying research participants or breaching applicable data protection law; 8. the applicant has not confirmed agreement to collaborate with Volition's Principal Investigator(s); 9. required ethics or IRB approval has not been obtained or evidenced; 10. other ethical reasons; or 11. the application is otherwise inconsistent with this policy If an application is rejected, the applicant will be notified with reasons tied to the specific terms of the DAA or this Policy. ________________________________________ Appeals Applicants who receive a rejection may submit a written appeal to the DAC within 30 calendar days of the notification. The appeal must set out the grounds on which the applicant contends the rejection was incorrect and provide any additional supporting evidence. The DAC will convene a review panel of at least two members not involved in the original decision. A response will be provided within 30 calendar days of receipt of the appeal. The appeal panel's decision is final. ________________________________________ Conditions of Approved Access Approved users are bound by the full terms of the DAA, including: 1. use of the data solely for the approved project and Research Purposes; 2. restriction of access to named authorised personnel only; 3. implementation and maintenance of appropriate data security measures; 4. agreement to observe the publication moratorium period specified in Appendix C of the DAA; 5. acknowledgement of Volition and the Data Producers in all publications; 6. notification of the DAC of any security incident within 72 hours of discovery; 7. destruction or return of all data upon request or at the end of the approved project; and 8. ongoing collaboration with Volition's Principal Investigator(s) in accordance with the COL DUO code. External collaborators wishing to access the data must submit a separate application and sign their own DAA before any data is shared with them. ________________________________________ Contact For questions about this Policy, the application process, or data access decisions, please contact Volition's Data Access Committee at: DAC@volition.com. All EGA studies and datasets referenced in publications must be publicly searchable on the EGA website before the paper is released. If you are preparing a publication using data accessed under this Policy, please notify the DAC in advance.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000001937 Epigenetics

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF50000914056 cram 78.7 MB
EGAF50000914057 crai 4.2 kB
EGAF50000914058 cram 294.7 MB
EGAF50000914059 crai 15.1 kB
EGAF50000914060 cram 90.6 MB
EGAF50000914061 crai 4.9 kB
EGAF50000914062 cram 64.1 MB
EGAF50000914063 crai 3.5 kB
EGAF50000914064 cram 51.8 MB
EGAF50000914065 crai 2.9 kB
EGAF50000914066 cram 398.4 MB
EGAF50000914067 crai 19.7 kB
EGAF50000914068 cram 71.4 MB
EGAF50000914069 crai 3.9 kB
EGAF50000914070 crai 6.6 kB
EGAF50000914071 cram 124.7 MB
EGAF50000914072 cram 31.7 MB
EGAF50000914073 crai 1.9 kB
EGAF50000914074 cram 38.2 MB
EGAF50000914075 crai 2.2 kB
EGAF50000914076 crai 25.4 kB
EGAF50000914077 cram 511.0 MB
EGAF50000914078 cram 19.3 MB
EGAF50000914079 crai 1.4 kB
EGAF50000914080 cram 91.8 MB
EGAF50000914081 crai 4.9 kB
EGAF50000914082 crai 3.2 kB
EGAF50000914083 cram 56.9 MB
EGAF50000914084 cram 38.4 MB
EGAF50000914085 crai 2.2 kB
EGAF50000914086 cram 71.4 MB
EGAF50000914087 crai 3.8 kB
EGAF50000914088 cram 78.3 MB
EGAF50000914089 crai 4.3 kB
EGAF50000914090 cram 56.3 MB
EGAF50000914091 crai 3.1 kB
EGAF50000914092 cram 32.3 MB
EGAF50000914093 crai 2.0 kB
EGAF50000914094 cram 180.9 MB
EGAF50000914095 crai 9.2 kB
EGAF50000914096 cram 53.9 MB
EGAF50000914097 crai 3.0 kB
EGAF50000914098 cram 34.1 MB
EGAF50000914099 crai 2.1 kB
EGAF50000914100 cram 30.5 MB
EGAF50000914101 crai 1.8 kB
EGAF50000914102 cram 48.0 MB
EGAF50000914103 crai 2.7 kB
EGAF50000914104 cram 49.6 MB
EGAF50000914105 crai 2.8 kB
EGAF50000914106 cram 134.9 MB
EGAF50000914107 crai 6.9 kB
EGAF50000914108 cram 87.9 MB
EGAF50000914109 crai 4.7 kB
EGAF50000914110 cram 506.6 MB
EGAF50000914111 crai 25.2 kB
EGAF50000914112 cram 174.1 MB
EGAF50000914113 crai 9.0 kB
EGAF50000914114 cram 270.6 MB
EGAF50000914115 crai 13.6 kB
EGAF50000914116 cram 432.1 MB
EGAF50000914117 crai 21.4 kB
EGAF50000914118 cram 197.2 MB
EGAF50000914119 crai 10.2 kB
EGAF50000914120 cram 397.7 MB
EGAF50000914121 crai 19.9 kB
EGAF50000914122 crai 8.9 kB
EGAF50000914123 cram 172.0 MB
EGAF50000914124 cram 219.3 MB
EGAF50000914125 crai 11.2 kB
EGAF50000914126 cram 102.9 MB
EGAF50000914127 crai 5.4 kB
EGAF50000914128 cram 277.0 MB
EGAF50000914129 crai 13.9 kB
EGAF50000914130 cram 48.8 MB
EGAF50000914131 crai 2.8 kB
EGAF50000914132 cram 128.0 MB
EGAF50000914133 crai 6.7 kB
EGAF50000914134 cram 15.1 MB
EGAF50000914135 crai 1.1 kB
EGAF50000914136 cram 102.5 MB
EGAF50000914137 crai 5.5 kB
EGAF50000914138 cram 15.3 MB
EGAF50000914139 crai 1.1 kB
EGAF50000914140 cram 21.7 MB
EGAF50000914141 crai 1.4 kB
EGAF50000914142 cram 22.7 MB
EGAF50000914143 crai 1.5 kB
EGAF50000914144 cram 20.4 MB
EGAF50000914145 crai 1.4 kB
EGAF50000914146 crai 7.8 kB
EGAF50000914147 cram 153.2 MB
EGAF50000914148 crai 18.0 kB
EGAF50000914149 cram 359.9 MB
EGAF50000914150 cram 44.7 MB
EGAF50000914151 crai 2.6 kB
EGAF50000914152 crai 7.9 kB
EGAF50000914153 cram 149.7 MB
EGAF50000914154 cram 77.1 MB
EGAF50000914155 crai 4.2 kB
EGAF50000914156 cram 104.7 MB
EGAF50000914157 crai 5.4 kB
EGAF50000914158 cram 117.8 MB
EGAF50000914159 crai 6.3 kB
EGAF50000914160 cram 58.4 MB
EGAF50000914161 crai 3.2 kB
EGAF50000914162 cram 44.3 MB
EGAF50000914163 crai 2.5 kB
EGAF50000914164 cram 39.0 MB
EGAF50000914165 crai 2.3 kB
EGAF50000914166 crai 1.8 kB
EGAF50000914167 cram 30.4 MB
EGAF50000914168 cram 74.8 MB
EGAF50000914169 crai 4.0 kB
EGAF50000914170 cram 70.3 MB
EGAF50000914171 crai 3.9 kB
EGAF50000914172 cram 35.7 MB
EGAF50000914173 crai 2.1 kB
EGAF50000914174 cram 129.2 MB
EGAF50000914175 crai 6.6 kB
EGAF50000914176 cram 250.7 MB
EGAF50000914177 crai 12.6 kB
EGAF50000914178 cram 71.9 MB
EGAF50000914179 crai 4.0 kB
EGAF50000914180 cram 94.3 MB
EGAF50000914181 crai 5.1 kB
EGAF50000914182 cram 72.4 MB
EGAF50000914183 crai 4.0 kB
EGAF50000914184 crai 17.0 kB
EGAF50000914185 cram 338.5 MB
EGAF50000914186 crai 4.4 kB
EGAF50000914187 cram 80.4 MB
EGAF50000914188 cram 27.1 MB
EGAF50000914189 crai 1.7 kB
EGAF50000914190 cram 14.9 MB
EGAF50000914191 crai 1.1 kB
EGAF50000914192 cram 103.2 MB
EGAF50000914193 crai 5.4 kB
EGAF50000914194 cram 81.5 MB
EGAF50000914195 crai 4.4 kB
EGAF50000914196 cram 10.8 MB
EGAF50000914197 crai 870 Bytes
EGAF50000914198 cram 5.0 GB
EGAF50000914199 crai 215.3 kB
EGAF50000914200 cram 25.4 MB
EGAF50000914201 crai 1.6 kB
EGAF50000914202 cram 6.0 GB
EGAF50000914203 crai 261.4 kB
EGAF50000914204 cram 5.1 MB
EGAF50000914205 crai 631 Bytes
EGAF50000914206 cram 6.1 GB
EGAF50000914207 crai 261.9 kB
EGAF50000914208 cram 33.6 MB
EGAF50000914209 crai 2.0 kB
EGAF50000914210 cram 6.8 GB
EGAF50000914211 crai 291.3 kB
EGAF50000914212 cram 7.0 MB
EGAF50000914213 crai 677 Bytes
EGAF50000914214 cram 23.3 MB
EGAF50000914215 crai 1.5 kB
EGAF50000914216 cram 15.1 MB
EGAF50000914217 crai 1.1 kB
EGAF50000914218 cram 22.7 MB
EGAF50000914219 crai 1.4 kB
EGAF50000914220 cram 112.0 MB
EGAF50000914221 crai 5.7 kB
EGAF50000914222 cram 22.8 MB
EGAF50000914223 crai 1.5 kB
EGAF50000914224 cram 18.9 MB
EGAF50000914225 crai 1.3 kB
EGAF50000914226 crai 3.9 kB
EGAF50000914227 cram 73.4 MB
EGAF50000914228 cram 24.2 MB
EGAF50000914229 crai 1.5 kB
EGAF50000914230 cram 7.7 MB
EGAF50000914231 crai 769 Bytes
EGAF50000914232 cram 24.3 MB
EGAF50000914233 crai 1.5 kB
EGAF50000914234 cram 164.4 MB
EGAF50000914235 crai 8.1 kB
EGAF50000914236 cram 9.5 MB
EGAF50000914237 crai 829 Bytes
EGAF50000914238 cram 13.1 MB
EGAF50000914239 crai 963 Bytes
EGAF50000914240 cram 24.3 MB
EGAF50000914241 crai 1.6 kB
EGAF50000914242 cram 25.8 MB
EGAF50000914243 crai 1.6 kB
EGAF50000914244 cram 29.2 MB
EGAF50000914245 crai 1.7 kB
EGAF50000914246 cram 16.2 MB
EGAF50000914247 crai 1.2 kB
EGAF50000914248 cram 19.3 MB
EGAF50000914249 crai 1.3 kB
EGAF50000914250 cram 16.3 MB
EGAF50000914251 crai 1.1 kB
EGAF50000914252 cram 14.4 MB
EGAF50000914253 crai 1.0 kB
EGAF50000914254 cram 3.9 MB
EGAF50000914255 crai 606 Bytes
EGAF50000914256 cram 8.1 MB
EGAF50000914257 crai 772 Bytes
EGAF50000914258 cram 12.7 MB
EGAF50000914259 crai 924 Bytes
EGAF50000914260 cram 29.7 MB
EGAF50000914261 crai 1.9 kB
EGAF50000914262 crai 4.0 kB
EGAF50000914263 cram 70.7 MB
EGAF50000914264 crai 2.4 kB
EGAF50000914265 cram 38.5 MB
EGAF50000914266 cram 49.8 MB
EGAF50000914267 crai 2.9 kB
EGAF50000914268 cram 15.5 MB
EGAF50000914269 crai 1.1 kB
EGAF50000914270 cram 24.6 MB
EGAF50000914271 crai 1.6 kB
EGAF50000914272 cram 78.5 MB
EGAF50000914273 crai 4.4 kB
EGAF50000914274 cram 81.3 MB
EGAF50000914275 crai 4.6 kB
EGAF50000914276 cram 23.6 MB
EGAF50000914277 crai 1.5 kB
EGAF50000914278 cram 18.9 MB
EGAF50000914279 crai 1.4 kB
EGAF50000914280 cram 301.5 MB
EGAF50000914281 crai 15.4 kB
EGAF50000914282 cram 62.5 MB
EGAF50000914283 crai 3.6 kB
EGAF50000914284 cram 92.0 MB
EGAF50000914285 crai 5.1 kB
EGAF50000914286 cram 58.3 MB
EGAF50000914287 crai 3.4 kB
EGAF50000914288 cram 140.2 MB
EGAF50000914289 crai 7.5 kB
EGAF50000914290 crai 2.7 kB
EGAF50000914291 cram 46.4 MB
EGAF50000914292 cram 42.7 MB
EGAF50000914293 crai 2.6 kB
EGAF50000914294 cram 30.6 MB
EGAF50000914295 crai 1.9 kB
EGAF50000914296 cram 87.7 MB
EGAF50000914297 crai 4.8 kB
EGAF50000914298 cram 100.9 MB
EGAF50000914299 crai 5.6 kB
EGAF50000914300 cram 24.2 MB
EGAF50000914301 crai 1.6 kB
EGAF50000914302 cram 43.7 MB
EGAF50000914303 crai 2.6 kB
EGAF50000914304 crai 8.2 kB
EGAF50000914305 cram 156.1 MB
EGAF50000914306 cram 19.1 MB
EGAF50000914307 crai 1.4 kB
EGAF50000914308 cram 124.6 MB
EGAF50000914309 crai 6.6 kB
EGAF50000914310 cram 14.1 MB
EGAF50000914311 crai 1.1 kB
EGAF50000914312 cram 28.0 MB
EGAF50000914313 crai 1.8 kB
EGAF50000914314 cram 19.2 MB
EGAF50000914315 crai 1.3 kB
EGAF50000914316 cram 30.8 MB
EGAF50000914317 crai 1.9 kB
EGAF50000914318 cram 10.7 MB
EGAF50000914319 crai 905 Bytes
EGAF50000914320 cram 11.9 MB
EGAF50000914321 crai 953 Bytes
EGAF50000914322 cram 8.7 MB
EGAF50000914323 crai 789 Bytes
EGAF50000914324 cram 12.2 MB
EGAF50000914325 crai 905 Bytes
EGAF50000914326 cram 10.3 MB
EGAF50000914327 crai 881 Bytes
EGAF50000914328 cram 35.9 MB
EGAF50000914329 crai 2.2 kB
EGAF50000914330 cram 17.6 MB
EGAF50000914331 crai 1.3 kB
EGAF50000914332 cram 16.2 MB
EGAF50000914333 crai 1.2 kB
EGAF50000914334 crai 1.9 kB
EGAF50000914335 cram 30.6 MB
EGAF50000914336 cram 49.0 MB
EGAF50000914337 crai 2.9 kB
EGAF50000914338 cram 35.1 MB
EGAF50000914339 crai 2.1 kB
EGAF50000914340 cram 15.1 MB
EGAF50000914341 crai 1.2 kB
EGAF50000914342 cram 107.2 MB
EGAF50000914343 crai 5.7 kB
EGAF50000914344 cram 33.4 MB
EGAF50000914345 crai 2.1 kB
EGAF50000914346 cram 61.0 MB
EGAF50000914347 crai 3.5 kB
EGAF50000914348 cram 65.5 MB
EGAF50000914349 crai 3.7 kB
EGAF50000914350 cram 208.9 MB
EGAF50000914351 crai 11.0 kB
EGAF50000914352 cram 106.0 MB
EGAF50000914353 crai 5.8 kB
EGAF50000914354 cram 98.5 MB
EGAF50000914355 crai 5.4 kB
EGAF50000914356 cram 31.4 MB
EGAF50000914357 crai 2.0 kB
EGAF50000914358 crai 3.4 kB
EGAF50000914359 cram 59.6 MB
EGAF50000914360 cram 225.9 MB
EGAF50000914361 crai 11.8 kB
EGAF50000914362 cram 44.9 MB
EGAF50000914363 crai 2.7 kB
EGAF50000914364 cram 23.3 MB
EGAF50000914365 crai 1.5 kB
EGAF50000914366 crai 9.1 kB
EGAF50000914367 cram 171.4 MB
EGAF50000914368 cram 32.6 MB
EGAF50000914369 crai 2.1 kB
EGAF50000914370 cram 103.7 MB
EGAF50000914371 crai 5.6 kB
EGAF50000914372 cram 19.7 MB
EGAF50000914373 crai 1.4 kB
EGAF50000914374 cram 16.1 MB
EGAF50000914375 crai 1.2 kB
320 Files (36.7 GB)